Prestige Consumer Healthcare
PBH
#4627
Rank
A$3.37 B
Marketcap
A$71.17
Share price
3.92%
Change (1 day)
-21.16%
Change (1 year)

P/S ratio for Prestige Consumer Healthcare (PBH)

P/S ratio as of November 2026 (TTM): 1.95

According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.19. At the end of 2023 the company had a P/S ratio of 2.68.

P/S ratio history for Prestige Consumer Healthcare from 2005 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.68-4.22%
20222.80-2.68%
20212.8757.36%
20201.83-14.52%
20192.1432.3%
20181.61-29.68%
20172.30-29.3%
20163.25-5.72%
20153.4426.98%
20142.71-10.89%
20133.0479.63%
20121.6920.28%
20111.41-26.67%
20101.9244.81%
20091.33-19.62%
20081.6543.07%
20071.15-43.19%
20062.03-4.25%
20052.12

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.85 251.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
4.56 133.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.27 170.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.59 32.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.96 103.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
1.85-4.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
0.2695-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.26 16.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
0.0016-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
2.64 35.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel